Literature DB >> 7119981

Serologic responses to Schistosoma japonicum: evaluation of total and parasite-specific immunoglobulins during the course of murine infection.

J V Little, C E Carter, D G Colley.   

Abstract

Mice with a primary infection of Schistosoma japonicum develop high levels of both total immunoglobulins and parasitic-specific antibodies, beginning about 1.5 wk after the onset of oviposition in the host. Radial immunodiffusion demonstrated an 18-fold, fivefold, and threefold increase in the levels of IgG1, IgM, and IgA, respectively, during the course of infection. Schistosoma japonicum-specific antibodies, as measured by an enzyme-linked immunoabsorbent assay, appeared and increased at about the same time as total immunoglobulins, and were predominantly of the IgG1 and IgM classes. The specific/ELISA response to a purified antigen from S. japonicum SEA was distinct from the total specific response to crude SEA. Hemagglutinating antibodies increased at 5 wk PI and remained at high levels for the duration of infection. Specific, circulating IgE measured by PCA appeared 6 wk PI, reaching a peak at 9 wk, and persisted at moderate levels throughout the infection period.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7119981

Source DB:  PubMed          Journal:  J Parasitol        ISSN: 0022-3395            Impact factor:   1.276


  3 in total

1.  Inhibition of immediate and Arthus responses to schistosome egg antigens by T cells from Schistosoma japonicum-infected mice.

Authors:  A B Stavitsky; G R Olds
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

2.  Mechanisms of in vivo modulation of granulomatous inflammation in murine schistosomiasis japonicum.

Authors:  G R Olds; A B Stavitsky
Journal:  Infect Immun       Date:  1986-05       Impact factor: 3.441

3.  Ocular sensitization of mice by live (but not irradiated) Chlamydia trachomatis serovar A.

Authors:  D G Colley; T G Goodman; I S Barsoum
Journal:  Infect Immun       Date:  1986-10       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.